Doctors and researchers at this year's EuroPCR conference look for answers in Medtronic's landmark SYMPLICITY HTN-3 clinical trial, which failed to find that renal denervation works against hypertension.
Amid the hand-wringing and back-pedaling surrounding renal denervation, some physicians are still looking for ways to use the technology to treat patients with hypertension.
News Well, Clinical Trials, Ablation, Hypertension, Conference coverage, EuroPCR, Renal, Research & Development
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1wfSm4y
Cap comentari:
Publica un comentari a l'entrada